Ignite Creation Date:
2025-12-25 @ 4:26 AM
Ignite Modification Date:
2026-03-27 @ 11:35 PM
Study NCT ID:
NCT01522820
Status:
COMPLETED
Last Update Posted:
2016-10-04
First Post:
2012-01-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors
Sponsor:
Roswell Park Cancer Institute
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Anaplastic Astrocytoma | View |
| None | Anaplastic Oligoastrocytoma | View |
| None | Anaplastic Oligodendroglioma | View |
| None | Estrogen Receptor Negative | View |
| None | Estrogen Receptor Positive | View |
| None | Glioblastoma | View |
| None | Hormone-Resistant Prostate Cancer | View |
| None | Metastatic Prostate Carcinoma | View |
| None | Metastatic Renal Cell Cancer | View |
| None | Recurrent Adult Brain Neoplasm | View |
| None | Recurrent Bladder Carcinoma | View |
| None | Recurrent Breast Carcinoma | View |
| None | Recurrent Colorectal Carcinoma | View |
| None | Recurrent Esophageal Carcinoma | View |
| None | Recurrent Gastric Carcinoma | View |
| None | Recurrent Hepatocellular Carcinoma | View |
| None | Recurrent Lung Carcinoma | View |
| None | Recurrent Melanoma | View |
| None | Recurrent Ovarian Carcinoma | View |
| None | Recurrent Prostate Carcinoma | View |
| None | Recurrent Renal Cell Carcinoma | View |
| None | Recurrent Uterine Corpus Carcinoma | View |
| None | Resectable Hepatocellular Carcinoma | View |
| None | Sarcoma | View |
| None | Stage IA Breast Cancer | View |
| None | Stage IA Ovarian Cancer | View |
| None | Stage IA Uterine Corpus Cancer | View |
| None | Stage IB Breast Cancer | View |
| None | Stage IB Ovarian Cancer | View |
| None | Stage IB Uterine Corpus Cancer | View |
| None | Stage IC Ovarian Cancer | View |
| None | Stage II Uterine Corpus Cancer | View |
| None | Stage IIA Breast Cancer | View |
| None | Stage IIA Lung Carcinoma | View |
| None | Stage IIA Ovarian Cancer | View |
| None | Stage IIB Breast Cancer | View |
| None | Stage IIB Esophageal Cancer | View |
| None | Stage IIB Lung Carcinoma | View |
| None | Stage IIB Ovarian Cancer | View |
| None | Stage IIB Skin Melanoma | View |
| None | Stage IIC Ovarian Cancer | View |
| None | Stage IIC Skin Melanoma | View |
| None | Stage IIIA Breast Cancer | View |
| None | Stage IIIA Esophageal Cancer | View |
| None | Stage IIIA Lung Carcinoma | View |
| None | Stage IIIA Ovarian Cancer | View |
| None | Stage IIIA Skin Melanoma | View |
| None | Stage IIIA Uterine Corpus Cancer | View |
| None | Stage IIIB Breast Cancer | View |
| None | Stage IIIB Esophageal Cancer | View |
| None | Stage IIIB Ovarian Cancer | View |
| None | Stage IIIB Skin Melanoma | View |
| None | Stage IIIB Uterine Corpus Cancer | View |
| None | Stage IIIC Breast Cancer | View |
| None | Stage IIIC Esophageal Cancer | View |
| None | Stage IIIC Ovarian Cancer | View |
| None | Stage IIIC Skin Melanoma | View |
| None | Stage IIIC Uterine Corpus Cancer | View |
| None | Stage IV Bladder Urothelial Carcinoma | View |
| None | Stage IV Esophageal Cancer | View |
| None | Stage IV Ovarian Cancer | View |
| None | Stage IV Prostate Cancer | View |
| None | Stage IV Skin Melanoma | View |
| None | Stage IVA Uterine Corpus Cancer | View |
| None | Stage IVB Uterine Corpus Cancer | View |
Keywords: